Recombinant Mouse Il25 Protein
| Cat.No. : | Il25-5210M |
| Product Overview : | Mouse Il25 (Q8VHC9) recombinant protein expressed in Escherichia coli. |
- Specification
- Gene Information
- Related Products
| Description : | Interleukin-25 (IL-25) – also known as interleukin-17E (IL-17E) – is a protein that in humans is encoded by the IL25 gene. |
| Source : | E. coli |
| Species : | Mouse |
| Form : | Lyophilized |
| Bio-activity : | The activity is determined by the dose-dependant production of IL-8 by human PBMCs. The expected ED50 for this effect is 322-488 ng/mL. |
| Molecular Mass : | 35.5 kDa |
| AA Sequence : | MVSLRIQEGCSHLPSCCPSKEQEPP EEWLKWSSASVSPPEPLSHTHHAES CRASKDGPLNSRAISPWSYELDRDL NRVPQDLYHARCLCPHCVSLQTGSH MDPLGNSVPLYHNQTVFYRRPCHGE EGTHRRYCLERRLYRVSLACVCVRP RVMA |
| Endotoxin : | < 0.1 EU/μg |
| Applications : | Functional Study SDS-PAGE |
| Storage : | Store at -20 centigrade on dry atmosphere. After reconstitution with sterilized water, store at -20 centigrade. Aliquot to avoid repeated freezing and thawing. |
| Storage Buffer : | No additive |
| Gene Name : | Il25 interleukin 25 [ Mus musculus ] |
| Official Symbol : | Il25 |
| Synonyms : | IL25; interleukin 25; interleukin-25; interleukin 17E; Il17e; IL-17e; |
| Gene ID : | 140806 |
| mRNA Refseq : | NM_080729 |
| Protein Refseq : | NP_542767 |
Products Types
| ◆ Recombinant Protein | ||
| IL25-509H | Recombinant Human IL25 Protein | +Inquiry |
| IL25-182H | Recombinant Active Human IL25 Protein, His-tagged(C-ter) | +Inquiry |
| Il25-183M | Recombinant Active Mouse IL25 Protein, His-tagged(C-ter) | +Inquiry |
| Il25-10584M | Recombinant Mouse Il25 Protein, His (Fc)-Avi-tagged | +Inquiry |
| IL25-166M | Recombinant Mouse IL25 Protein | +Inquiry |
| ◆ Lysates | ||
| IL25-2920HCL | Recombinant Human IL25 cell lysate | +Inquiry |
| IL25-2910MCL | Recombinant Mouse IL25 cell lysate | +Inquiry |
| IL25-1261RCL | Recombinant Rat IL25 cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionThere is a lack of conclusive evidence that IL-25 has a clear effect in tumor treatment, but there are some studies underway.
There are no clear studies on the side effects of IL-25, but the patient response needs to be closely monitored during research and clinical application.
In addition to treating asthma and inflammatory bowel disease, IL-25 may also have potential applications in the treatment of lung infections, urticaria and other diseases.
IL-25 activates specific signaling pathways by binding to specific receptors, thereby regulating the activity of immune cells and the degree of inflammation in the body.
Some studies have shown that recombinant IL-25 can improve symptoms of diseases such as asthma and inflammatory bowel disease, but more research is needed to verify its efficacy.
Yes, in general, IL-25 therapy needs to be administered by injection to ensure that the protein can enter the body and work.
Customer Reviews (3)
Write a reviewEfficacy of the protein can be evaluated by observing its pharmacokinetics, pharmacodynamics and toxicity in mice or rats. -
Animal models were used to evaluate the efficacy and side effects of the remade proteins. -
Storage is stable, and the environmental requirements are not harsh. -
Ask a Question for All Il25 Products
Required fields are marked with *
My Review for All Il25 Products
Required fields are marked with *
Inquiry Basket
